ITRM920535A1 - Composizione farmaceutica per la somministrazione attraverso le mucose. - Google Patents

Composizione farmaceutica per la somministrazione attraverso le mucose.

Info

Publication number
ITRM920535A1
ITRM920535A1 IT000535A ITRM920535A ITRM920535A1 IT RM920535 A1 ITRM920535 A1 IT RM920535A1 IT 000535 A IT000535 A IT 000535A IT RM920535 A ITRM920535 A IT RM920535A IT RM920535 A1 ITRM920535 A1 IT RM920535A1
Authority
IT
Italy
Prior art keywords
mucoses
administration
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IT000535A
Other languages
English (en)
Inventor
Moise Azria
Gerd Fricker
Jacky Vonderscher
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919115202A external-priority patent/GB9115202D0/en
Priority claimed from GB929200748A external-priority patent/GB9200748D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ITRM920535A0 publication Critical patent/ITRM920535A0/it
Publication of ITRM920535A1 publication Critical patent/ITRM920535A1/it
Application granted granted Critical
Publication of IT1263222B publication Critical patent/IT1263222B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ITRM920535A 1991-07-15 1992-07-14 Composizione farmaceutica per la somministrazione attraverso le mucose. IT1263222B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919115202A GB9115202D0 (en) 1991-07-15 1991-07-15 Improvements relating to organic compounds
GB929200748A GB9200748D0 (en) 1992-01-14 1992-01-14 Improvements relating to organic compounds

Publications (3)

Publication Number Publication Date
ITRM920535A0 ITRM920535A0 (it) 1992-07-14
ITRM920535A1 true ITRM920535A1 (it) 1994-01-14
IT1263222B IT1263222B (it) 1996-08-05

Family

ID=26299234

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920535A IT1263222B (it) 1991-07-15 1992-07-14 Composizione farmaceutica per la somministrazione attraverso le mucose.

Country Status (7)

Country Link
JP (1) JPH05194260A (it)
BE (1) BE1007752A5 (it)
CH (1) CH685600A5 (it)
DE (1) DE4222647A1 (it)
FR (1) FR2682598B1 (it)
GB (1) GB2257908B (it)
IT (1) IT1263222B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
US5698521A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Native calcitonin mimetics
WO1997021448A1 (en) * 1995-12-13 1997-06-19 Dullatur Limited A calcitonin preparation
GB9614235D0 (en) * 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
AU726940B2 (en) 1997-04-14 2000-11-23 Mitsubishi-Tokyo Pharmaceuticals, Inc. Permucosal preparation
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid
GB2218102B (en) * 1988-04-08 1992-09-16 Sandoz Ltd Calcitonin peptide derivatives
HU206367B (en) * 1988-04-30 1992-10-28 Sandoz Ag Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts
JP2911496B2 (ja) * 1989-09-11 1999-06-23 帝國製薬株式会社 生理活性ポリペプチド含有高吸収性経膣剤
ES2067624T3 (es) * 1989-11-16 1995-04-01 Ph & T S R L Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal.

Also Published As

Publication number Publication date
IT1263222B (it) 1996-08-05
BE1007752A5 (fr) 1995-10-17
FR2682598B1 (fr) 1996-04-05
JPH05194260A (ja) 1993-08-03
ITRM920535A0 (it) 1992-07-14
FR2682598A1 (fr) 1993-04-23
GB2257908A (en) 1993-01-27
CH685600A5 (de) 1995-08-31
GB9214830D0 (en) 1992-08-26
GB2257908B (en) 1995-12-20
DE4222647A1 (de) 1993-01-21

Similar Documents

Publication Publication Date Title
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
FI922958A0 (fi) Farmaceutisk sammansaettning.
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
FI922252A0 (fi) Farmaceutisk sammansaettning.
FI922316A0 (fi) Farmaceutisk sammansaettning.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
ITRM910696A1 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
FI923581A0 (fi) Farmaceutisk kombinationsformation.
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
FI922364A0 (fi) Farmaceutiska kompositioner.
FI901102A0 (fi) Farmaceutiska kompositioner.
GR3036937T3 (en) Pharmaceutical formulations.
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
ATE71837T1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
DE69006094D1 (de) Pharmazeutische Zusammensetzungen.
FI893643A0 (fi) Farmaceutiska kompositioner.
DZ1559A1 (fr) Compositions pharmaceutiques.
FI910088L (fi) Oral farmaceutisk komposition.
MX9200532A (es) Agente farmaceuticos.
FI921876A7 (fi) Farmaseuttinen koostumus, joka sisältää diritromysiiniä
ITRM920535A1 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
FI913639A7 (fi) Farmaceutiska kompositioner.
FI923371A0 (fi) En farmaceutisk formulation.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960927